Hepatic arterial infusion pump (HAIP) chemotherapy

Project summary

The Erasmus MC Cancer Institute in Rotterdam, the Netherlands, has started a new program on Hepatic Arterial Infusion Pump (HAIP) chemotherapy for patients with liver tumours. In close collaboration with the Memorial Sloan Kettering Cancer Center (MSKCC) the program will start with the PUMP trial. The PUMP trial focusses on patients with resectable colorectal liver metastases. In the near future our programme will be extended for patients with primary liver tumors (intrahepatic cholangocarcinoma).